Vivan Therapeutics

Vivan Therapeutics is revolutionising cancer treatment by generating novel, personalised drug cocktails targeted to an individual’s cancer. The company utilises a comprehensive in vivo drug screening technology developed at and in partnership with the Icahn School of medicine at Mount Sinai Medical Center, New York. Using robotics, thousands of FDA approved drugs, including non-cancer drugs, are screened in combinations to identify drug cocktails designed to target the tumour specifically. Vivan Therapeutics is building a powerful AI-driven digital health tool, which can predict effective treatment recommendations rapidly, making it highly scalable and attractive to healthcare providers, pharma and insurers.

• Oncology